Daptomycin for Injection

What is Daptomycin for Injection?
Daptomycin for Injection is a cyclic lipopeptide antibiotic used for the treatment of serious gram-positive bacterial infections, including MRSA and VRE. It is administered intravenously and is widely used in hospitals and ICU settings for infections that do not respond to standard antibiotics.
 
Uses of Daptomycin for Injection
• Treatment of complicated skin and soft tissue infections (cSSTI)
• Management of Staphylococcus aureus bloodstream infections
• Treatment of right-sided infective endocarditis
• Effective against MRSA (Methicillin-resistant Staphylococcus aureus)
• Effective against VRE (Vancomycin-resistant Enterococci)
• Used in cases where vancomycin or linezolid fail or are not tolerated
 
How Does Daptomycin for Injection Work?
Daptomycin works by binding to bacterial cell membranes, causing rapid depolarization and loss of essential ions, ultimately leading to bacterial cell death. It shows rapid bactericidal activity and is especially effective against resistant gram-positive organisms. Unlike many antibiotics, it does not affect bacterial protein or DNA synthesis.
 
Frequently Asked Questions (FAQs)
Q: Who is a leading manufacturer of Daptomycin for Injection in India?
A: Farbe Firma Pvt Ltd is a premier manufacturer and global supplier of Daptomycin for Injection (Daptosyl). We produce high-quality sterile cyclic lipopeptide antibiotic injectables in our WHO-GMP certified facility, ensuring strict adherence to international standards (USP/BP/IP) for treating severe, resistant infections.
Q: What strengths and packaging options does Farbe Firma offer for Daptomycin Injection?
A: We manufacture Daptomycin for Injection in the strength of 500 mg. The product is supplied as a lyophilized vial, requiring reconstitution for intravenous (IV) infusion. We offer customizable packaging solutions to meet specific hospital and international market requirements.
Q: Can Farbe Firma provide regulatory dossiers (CTD/ACTD) for Daptomycin Injection export?
A: Yes, we specialize in global pharmaceutical exports. Farbe Firma provides comprehensive regulatory support, including CTD and ACTD dossiers, Certificate of Pharmaceutical Product (COPP), and Free Sale Certificates (FSC) to facilitate smooth registration in LATAM, CIS, Africa, and Southeast Asia.
Q: Does Farbe Firma offer Contract Manufacturing (CMO) for Antibiotics against MDR Bacteria?
A: Absolutely. We offer third-party contract manufacturing (CMO) and private labeling services for Daptomycin for Injection. Pharmaceutical companies looking for a reliable partner for sterile antibiotic production against multidrug-resistant (MDR) bacteria can leverage our advanced manufacturing capabilities.
Q: What is the therapeutic indication and key feature of the Daptomycin produced by Farbe Firma?
A: Our Daptomycin for Injection is indicated for the treatment of complicated skin and soft tissue infections (cSSTI) and Staphylococcus aureus bloodstream infections (bacteremia), including cases caused by Methicillin-resistant S. aureus (MRSA) and Vancomycin-resistant Enterococci (VRE). It is a critical, rapidly bactericidal drug for serious gram-positive resistance.
 
Looking for a reliable Daptomycin for Injection manufacturer?
Contact Farbe Firma Pvt. Ltd. for CTD dossier support, regulatory registration assistance, and global export supplies of Daptomycin for Injection.